Validation of a measure of contraceptive self-injection self-efficacy in Uganda

Sexual and reproductive health self-care interventions, including self-administered injectable contraception, can promote individual agency and health. As an increasing number of programs seek to introduce and expand access to self-injectable contraception, it’s imperative to develop measures that define programmatic success based on whether people have the opportunity to make a decision about self-injectable use with agency, rather than relying on measures of self-injectable uptake. We performed psychometric evaluation to validate a self-injectable self-efficacy scale using cross-sectional survey data collected among 2,369 sexually active, reproductive aged women in Uganda. We examined descriptive statistics of a pool of five potential items before conducting an Exploratory Factor Analysis to determine factor structure and reduce the item pool. We ran a Confirmatory Factor Analysis to confirm the factor structure and performed a correlation analysis to determine whether the final self-injectable self-efficacy scale was correlated with items related to contraceptive decision-making self-efficacy and previous self-injectable use. Our final measure of self-injectable self-efficacy is a unidimensional scale that contains three items: 1) “I feel confident that I could self-inject on my own at the end of training,” 2) “I feel confident that I can do all the steps correctly and will be protected from pregnancy,” and 3) “I can manage to self-inject even if I feel very scared at first.” Self-injectable self-efficacy was positively and significantly correlated with prior self-injectable use and items related to contraceptive decision-making self-efficacy. We validated a novel self-care focused measure of self-injectable self-efficacy in Uganda. Self-injectable self-efficacy, which can be measured among all reproductive-aged women regardless of prior self-injectable training or use, can be used to evaluate self-injectable programs to determine whether programs equip people with the tools needed to successfully use self-injectable contraception if they desire.

Authors

Institutions

Publication Details

Journal
BMC Women s Health
Published
2025-09-22
DOI
https://doi.org/10.1186/s12905-025-03982-y
Primary Topic
Reproductive Health and Contraception
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Validation of a measure of contraceptive self-injection self-efficacy in Uganda

Brooke W. Bullington, Sneha Challa, Catherine Birabwa, Dinah Amongin et al.
BMC Women s Health
Reproductive Health and Contraception
article

Validation of a measure of contraceptive self-injection self-efficacy in Uganda

Brooke W. Bullington, Sneha Challa, Catherine Birabwa, Dinah Amongin, Jane Cover, Peter Waiswa, Kelsey Holt, Ronald Wasswa, Sylvia Nanono
article en

Abstract

Sexual and reproductive health self-care interventions, including self-administered injectable contraception, can promote individual agency and health. As an increasing number of programs seek to introduce and expand access to self-injectable contraception, it’s imperative to develop measures that define programmatic success based on whether people have the opportunity to make a decision about self-injectable use with agency, rather than relying on measures of self-injectable uptake. We performed psychometric evaluation to validate a self-injectable self-efficacy scale using cross-sectional survey data collected among 2,369 sexually active, reproductive aged women in Uganda. We examined descriptive statistics of a pool of five potential items before conducting an Exploratory Factor Analysis to determine factor structure and reduce the item pool. We ran a Confirmatory Factor Analysis to confirm the factor structure and performed a correlation analysis to determine whether the final self-injectable self-efficacy scale was correlated with items related to contraceptive decision-making self-efficacy and previous self-injectable use. Our final measure of self-injectable self-efficacy is a unidimensional scale that contains three items: 1) “I feel confident that I could self-inject on my own at the end of training,” 2) “I feel confident that I can do all the steps correctly and will be protected from pregnancy,” and 3) “I can manage to self-inject even if I feel very scared at first.” Self-injectable self-efficacy was positively and significantly correlated with prior self-injectable use and items related to contraceptive decision-making self-efficacy. We validated a novel self-care focused measure of self-injectable self-efficacy in Uganda. Self-injectable self-efficacy, which can be measured among all reproductive-aged women regardless of prior self-injectable training or use, can be used to evaluate self-injectable programs to determine whether programs equip people with the tools needed to successfully use self-injectable contraception if they desire.

BMC Women s HealthVol. 25(S1)
Program for Appropriate Technology in Health (US), University of California, San Francisco (US), University of Utah (US), University of Utah Hospital (US), Institute on Aging (US), Makerere University (UG)
Bill and Melinda Gates Foundation, National Institutes of Health, University of North Carolina at Chapel Hill, Carolina Population Center, University of North Carolina at Chapel Hill
Openalex Percentile: Top 65%
Reproductive Health and Contraception
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.